Astrazeneca (AZN) EBT Margin (2009 - 2026)
Astrazeneca (AZN) reported EBT Margin of 18.19% for Q2 2026, down 3.44 percentage points from 21.63% a year earlier and down 7.41 percentage points from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EBT Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Astrazeneca's EBT Margin came in at 39.20%, up 21.46 percentage points year-over-year; for FY2025, it came in at 21.11%, up 5.04 percentage points from FY2024.
- EBT Margin has increased for four consecutive years, with a five-year change of +6.40 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at 16.07% in FY2024 (+1.01 pp), 15.06% in FY2023 (+9.42 pp), 5.64% in FY2022 (+6.35 pp) and -0.71% in FY2021 (-15.42 pp).
- The Q2 2026 figure ranks as the lowest quarterly EBT Margin since Q4 2024.
- Year over year, EBT Margin gained in six of the last eight quarters, with an average year-over-year change of +11.71 percentage points.
- The high point for year-over-year EBT Margin in five years was Q4 2025 (a gain of 79.77 percentage points); the low point was Q3 2021 (a drop of 33.25 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 25.60% (Q1 2026), 90.96% (Q4 2025) and 21.35% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.23 Bn | 1,139.82 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 648.76 Bn | 568.62 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 503.78 Bn | 476.89 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 366.20 Bn | 320.58 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 303.55 Bn | 267.54 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 269.42 Bn | 243.11 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 195.01 Bn | 169.21 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 172.42 Bn | 119.07 Bn | 10.94 Bn | -4.34% |
| 10 | Vertex Pharmaceuticals | 136.07 Bn | 108.07 Bn | 2.84 Bn | 41.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.19% |
| Mar 31, 2026 | 27.21% |
| Dec 31, 2025 | 18.08% |
| Sep 30, 2025 | 22.58% |
| Jun 30, 2025 | 21.63% |
| Mar 31, 2025 | 26.42% |
| Dec 31, 2024 | 12.47% |
| Sep 30, 2024 | 14.12% |
| Jun 30, 2024 | 18.53% |
| Mar 31, 2024 | 22.99% |
| Dec 31, 2023 | 7.92% |
| Sep 30, 2023 | 14.99% |
| Jun 30, 2023 | 18.29% |
| Mar 31, 2023 | 21.41% |
| Dec 31, 2022 | 7.21% |
| Sep 30, 2022 | 8.71% |
| Jun 30, 2022 | 2.29% |
| Mar 31, 2022 | 5.04% |
| Dec 31, 2021 | -5.53% |
| Sep 30, 2021 | -20.54% |
API Access
Astrazeneca EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();